Advertisement

Topics

SERVIER Company Profile

12:41 EST 16th December 2018 | BioPortfolio

Nil

Location

22 rue Garnier
NEUILLY-SUR-SEINE
CEDEX
92578
France

Contact

Phone: 33 1 55 72 60 00


News Articles [37 Associated News Articles listed on BioPortfolio]

Servier expands global footprint post Shire deal

Following its acquisition of Shire’s oncology business in April, Servier is taking steps to expand its presence in the US and China. The French pharma company has announced the opening of the Servi...

Servier finalizes acquisition of Shire’s oncology branch

Servier announced that it has finalized the previously announced acquisition of Shire’s oncology branch after obtaining regulatory clearance. The 2.4 billion dollar transaction will enable Servier t...

Servier and Galapagos begin ROCCELLA trial

Servier and Galapagos have commenced the ROCCELLA Phase 2 clinical trial to evaluate the efficacy and safety of S201086/GLPG1972 to...Read More... The post Servier and Galapagos begin ROCCELLA trial a...

Shire divests oncology business to Servier for $2.4bn

Shire has concluded the divestiture of its Oncology unit to French pharmaceutical company Servier for a total consideration of $2.4bn....Read More... The post Shire divests oncology business to Servie...

Servier Taps Shire Veteran To Helm New U.S. Subsidiary

French biotech company Servier is setting up shop in Boston following its April deal to acquire Shire’s oncology business for $2.4 billion.

Shire hands over its oncology franchise to Servier for $2.4bn

Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global and regional rights to a slew of pipeline products including acute lymphoblastic...

CTI, Servier’s Pixuvri fails in post-marketing trial

A late-stage trial of Servier and CTI BioPharma’s Pixuvri in combination with Roche's MabThera has failed to hit targets in B-cell non-Hodgkin lymphoma, putting its conditional approval in Europ...

Shire sells Oncology Portfolio to Servier

Ahead of its acquisition by Japan’s Takeda Pharmaceutical, Ireland-domiciled, London-listed and US-focused Shire has completed the sale of its oncology portfolio with $262 million in annual sale...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Multiple-therapy-resistant major depressive disorder: a clinically important concept.

SummaryMany novel therapeutic options for depression exist that are either not mentioned in clinical guidelines or recommended only for use in highly specialist services. The challenge faced by clinic...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Gliclazide 120 mg Modified Release Tablets

The main purpose of this study is to assess comparative bioavailability of two test formulations of Gliclazide 120 mg Modified Release tablets (120 mg gliclazide per modified release table...

Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations

The purpose of the study is to compare the bioavailability of a generic product of gliclazide (Product Name: BF-Gliclazide Tablet 80mg, Manufactured by Bright Future Pharmaceuticals Factor...

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.multiple daily injections, 3.anti-hyperglycemi...

Companies [9 Associated Companies listed on BioPortfolio]

incorporated company of SERVIER

The leading Frenchindependent pharmaceutical company Reference productsfor diseases of major importance 17 500 employees worldwide,including 2500 in Research and Development Established...

SERVIER

Nil

DW Coordinating Center

Since 1989, DW Coordinating Center and its partner, Clinical Pharmacological Research (CPR), St. Petersburg, Russia, have conducted major multinational clinical trials in the former Soviet Union for H...

Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward’s products and services have been utilized in o...

Phase Forward Incorporated

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 1...

More Information about "SERVIER" on BioPortfolio

We have published hundreds of SERVIER news stories on BioPortfolio along with dozens of SERVIER Clinical Trials and PubMed Articles about SERVIER for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SERVIER Companies in our database. You can also find out about relevant SERVIER Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record